000279885 001__ 279885
000279885 005__ 20250716101215.0
000279885 013__ $$aEP-2878677-A1
000279885 0247_ $$2Patent$$aEP2878677A1
000279885 037__ $$aDZNE-2025-00852
000279885 1001_ $$0P:(DE-HGF)0$$aGroll, Michael$$b0
000279885 245__ $$aActivators of protein phosphatase 5
000279885 260__ $$c2015
000279885 3367_ $$2ORCID$$aPATENT
000279885 3367_ $$0PUB:(DE-HGF)23$$2PUB:(DE-HGF)$$aPatent$$bpatent$$mpatent$$s1752572536_17592
000279885 3367_ $$2DRIVER$$apatent
000279885 3367_ $$2BibTeX$$aTECHREPORT
000279885 3367_ $$015$$2EndNote$$aPatent
000279885 3367_ $$2DataCite$$aPatent
000279885 520__ $$aThe present invention relates to compounds that show a positive result in a phosphatase activation assay with protein phosphatase 5 according to the invention, to compounds that bind in an in vitro binding assay to a certain region of the amino acid sequence of protein phosphatase 5, as well as to compounds that show a positive result in a phosphatase activation assay with protein phosphatase 5 according to the invention and bind in an in vitro binding assay to a certain region of the amino acid sequence of protein phosphatase 5. The present invention also relates to pharmaceutical compositions comprising one or more of such compounds, to methods of using such a compound, and to methods of screening for compounds that activate protein phosphatase 5.
000279885 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000279885 7001_ $$0P:(DE-HGF)0$$aRichter, Klaus$$b1
000279885 7001_ $$0P:(DE-HGF)0$$aHaslbeck, Veronika$$b2
000279885 7001_ $$0P:(DE-2719)9000420$$aStriggow, Frank$$b3
000279885 7001_ $$0P:(DE-HGF)0$$aMartin, Helmuth$$b4
000279885 7001_ $$0P:(DE-2719)9000421$$aSchmidt, Werner$$b5
000279885 7001_ $$0P:(DE-HGF)0$$aWeiwad, Matthias$$b6
000279885 7001_ $$0P:(DE-HGF)0$$aFischer, Gunter$$b7
000279885 8564_ $$uhttps://pub.dzne.de/record/279885/files/DZNE-2025-00852_Restricted.pdf
000279885 8564_ $$uhttps://pub.dzne.de/record/279885/files/DZNE-2025-00852_Restricted.pdf?subformat=pdfa$$xpdfa
000279885 909CO $$ooai:pub.dzne.de:279885$$pVDB
000279885 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000420$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000279885 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000421$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b5$$kDZNE
000279885 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000279885 9201_ $$0I:(DE-2719)5000045$$kAG Striggow$$lNeurodegeneration and Intervention Strategies$$x0
000279885 980__ $$apatent
000279885 980__ $$aVDB
000279885 980__ $$aI:(DE-2719)5000045
000279885 980__ $$aUNRESTRICTED